# Relmada Therapeutics, Inc.: Form S-1/A, filed Oct 11, 2019

- Company: [Relmada Therapeutics, Inc.](/companies/rlmd.md) (CIK 1553643)
- Form: S-1/A
- Filed: 2019-10-11
- Accepted by EDGAR: Oct 11, 2019, 16:23 ET
- Period: not reported
- Accession: 0001213900-19-020211
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1553643/000121390019020211/fs12019a1_relmadatherape.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1553643/000121390019020211/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1553643/000121390019020211/fs12019a1_relmadatherape.htm

Filed Oct 11, 2019.
Source: SEC EDGAR, the filing index for accession 0001213900-19-020211. Last ingested by Listed: Nov 13, 2026, 15:42 ET. No prices; not investment advice.
